(Q35085299)

6 August 2017

1 reference

title

Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis (English)

1 reference

6 August 2017

1 reference

Christine Mannhalter

2

0 references

author name string

Georg Endler

series ordinal

1

1 reference

6 August 2017

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

330

1 reference

6 August 2017

1-2

1 reference

6 August 2017

31-55

1 reference

Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Contact system. New concepts on activation mechanisms and bioregulatory functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Interactions of intercellular adhesion molecule-1 with fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Molecular cloning of a cDNA encoding human antihaemophilic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

A study of twins and stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Concordance for mortality with special reference to ischaemic heart disease and cerebrovascular disease. A study on the Swedish Twin Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Role of inflammation in coronary plaque disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

7 January 2021

Atheroma: more than mush

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Homozygosity for the C-->T polymorphism at nucleotide 46 in the 5' untranslated region of the factor XII gene protects from development of acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor XI activation in a revised model of blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Activation of clotting factors XI and IX in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

RFLP for intron E of factor XI gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor IX gene polymorphisms in Indian population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Activated protein C accelerates clot lysis by virtue of its anticoagulant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The molecular biology of von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The -1185 A/G and -1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

ABO blood group system, age, sex, risk factors and cardiac infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

ABO blood-groups and myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic determinants of arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Lack of association between polymorphisms of the coagulation factor VII and myocardial infarction in middle-aged Spanish men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Activation of human factor V by factor Xa and thrombin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Subcellular localization and secretion of factor V from human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Do inherited prothrombotic factors have a role in myocardial infarction with normal coronary arteriogram?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

A prospective study of venous thromboembolism in relation to factor V Leiden and related factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Inherited protein-C deficiency, factor V G 1691 A and FV A 4070 G mutations in a child with internal cerebral venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Prothrombin and the prothrombin 20210 G to A polymorphism: their relationship with hypercoagulability and thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Fibrinogen as a risk factor for stroke and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic and cultural inheritance of plasma fibrinogen concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic factors determining thrombosis and fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Control of plasma fibrinogen levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Fibrinogen polymorphisms are not associated with the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Blood coagulation factor XIII: structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The role of factor XIIIVal34Leu in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Stroke trends in Rochester, Minnesota, during 1945 to 1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Venous thromboembolism epidemiology: implications for prevention and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Mutation in blood coagulation factor V associated with resistance to activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

[Recurrent venous thromboses in hypoplasia of the vena cava inferior and factor XII deficiency]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Reevaluation of the Incidence of Thromboembolic Complications in Congenital Factor XII Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

High levels of coagulation factor XI as a risk factor for venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Conserved worldwide linkage disequilibrium in the human factor XI gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Dinucleotide repeat polymorphism in the human coagulation factor XI gene, intron B (F11), detected using the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

7 January 2021

Factor IX and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic mechanisms of age regulation of blood coagulation: factor IX model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

High plasma levels of factor VIII and the risk of recurrent venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Resistance to activated protein C as a basis for venous thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Inherited Thrombophilia due to Factor V Leiden Mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factors. East Anglian Thrombophilia Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Long-term treatment for venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The thrombophilias: well-defined risk factors with uncertain therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor V Leiden and a First Spontaneous Venous Thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Inherited thrombophilias in pregnant patients: detection and treatment paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Inherited thrombophilia and pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Prothrombin G20210A polymorphism and thrombophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Homozygous patients with the 20210 G to A prothrombin polymorphism remain often asymptomatic in spite of the presence of associated risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic risk factors of venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

The current status of coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

Genetic polymorphisms of factor VII are not associated with arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Oxygen and placental vascular development

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900022-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-8981(03)00022-6

1 reference

release_acydtmhiwraqdaogn4xo5qnuee

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/acydtmhiwraqdaogn4xo5qnuee

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12636925

1 reference

PubMed ID

12636925